PDS Biotechnology Corp (PDSB)
Healthcare
Biotechnology
0.69 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
PDS Biotechnology Corp (PDSB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -4,372 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.8 | -7.2 | -8.5 | -9.9 | -8.9 | -8.0 | -8.2 | -9.0 | -9.1 | -5.9 | -3.7 | -4,372 | -4,390 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1,185 | 0.0 | -1,185 | |
| 2.1 | 2.1 | 1.4 | 1.6 | 1.8 | 1.8 | 1.6 | 1.3 | 0.4 | 1.2 | -1,795 | 1.2 | -1,792 | |
| 2.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.8 | 1.4 | 0.4 | -1.2 | -0.1 | 0.6 | -2.2 | -2.3 | -1.2 | 1.4 | 1.8 | 1.4 | 3.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | 0.0 | -29 | – | – | – | – | – | – | |
| 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | 0.0 | -3.1 | -3.1 | -0.5 | -1.0 | -2.9 | -1.5 | -5.9 | |
| 0.2 | 0.8 | 11 | 20 | 0.0 | 0.0 | 0.2 | 7.3 | 1.0 | 0.2 | 4.2 | -680 | -674 | |
| -4.6 | -6.4 | 2.3 | 10 | -8.9 | -8.0 | -8.1 | -1.7 | -8.1 | -5.7 | 0.5 | -5,051 | -5,065 | |
| -4.8 | -7.2 | -8.5 | -9.9 | -8.9 | -8.0 | -8.2 | -9.0 | -9.1 | -5.9 | -3.7 | -4,372 | -4,390 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.